Investment Pitches

Pitch Summary:
Village Super Market is currently trading at approximately 9.5x scalpavelli-adjusted trailing earnings with a 33% net cash position and a 10% working capital deficit. Despite the chaotic price action, the company's strong balance sheet and modest growth potential from a sub-10x earnings base level make it a value trap that is comfortable to hold. However, recent disputes with Wakefern and aggressive capital expenditure plans limit the potential for a special dividend in the near future. These factors lead to the assessment that the stock is approximately fairly priced at the moment.

BSD Analysis:
Village Super Market's management has been criticized for poor investment decisions and low shareholder returns, which justifies its low valuation multiple. The company's digital sales growth has accelerated, but the marginal economics remain uncertain. The ongoing disputes with Wakefern and the aggressive capex plans suggest limited upside potential. Investors should be cautious of the company's ability to generate significant returns in the near term, given its current strategic challenges and market conditions.

Pitch Summary:
WeightWatchers is positioned to benefit significantly from the FDA approval of oral Wegovy, as it could become the operating system connecting the drug to millions of patients. The company's platform is anticipated to compound 100× over the long term if oral GLP-1s scale effectively. With the approval, WeightWatchers can activate during the crucial January acquisition window, leveraging its platform to capture momentum in the weight management market. The company's strategic positioning and readiness to integrate with new obesity treatments underscore its potential for substantial growth.

BSD Analysis:
WeightWatchers' strategic alignment with the launch of oral Wegovy positions it to capture a significant share of the expanding obesity treatment market. The company's ability to act as an intermediary between patients and the new treatment could drive exponential growth. The timing of the FDA approval allows WeightWatchers to capitalize on the critical January engagement period, enhancing its market presence. As oral GLP-1s gain traction, WeightWatchers' platform could see increased adoption, driving long-term value creation. The company's resilience through recent market fluctuations further highlights its potential as a growth leader in the wellness industry.

Pitch Summary:
Novo Nordisk has received FDA approval for oral Wegovy, marking a significant milestone as the first oral GLP-1 treatment for the US obesity market. This approval positions Wegovy as a chronic disease therapy, not just a cosmetic weight-loss product, with an on-label claim for reducing cardiovascular risks. The company is prepared for a full US launch in early January 2026, with manufacturing underway and robust supply on-hand, addressing previous supply constraints. The pricing strategy makes Wegovy the most affordable self-pay GLP-1 obesity option Novo has launched, supporting rapid uptake. Market consensus underestimates Novo's growth potential, as oral Wegovy is set to generate immediate revenue, challenging the expectation of a sales decline in 2026.

BSD Analysis:
Novo Nordisk's strategic readiness for the US launch of oral Wegovy, with manufacturing already in progress, positions the company to capitalize on the obesity market swiftly. The affordable pricing strategy directly addresses adoption barriers, potentially accelerating market penetration. Despite market consensus predicting a sales decline, Novo's recent 15% revenue growth and the new product launch suggest otherwise. The current valuation, with a P/E of 12.3×, undervalues Novo's growth prospects. A re-rating towards a 25× earnings multiple could lead to significant stock appreciation, reflecting the company's potential to redefine the obesity treatment landscape.

Pitch Summary:
@CorneliaLake highlights a newly published short report on T1 Energy while arguing the market is over-fixated on legacy negatives and underweighting recent fundamental progress. The company is positioned as a domestic solar manufacturing platform, where customer diligence and supply-chain compliance matter as much as near-term earnings optics. The key catalyst in the post is a newer commercial agreement with a well-capitalized developer backed by a major infrastructure sponsor, which the author frames as more probative than older contract noise. The author also points to substantial capital raising and detailed company communication as supportive evidence that the compliance debate is being addressed rather than ignored. The implicit valuation angle is that shorts are targeting a liquid name after a strong move, but the author believes the setup may be “special” given incremental validation from counterparties. Risks include policy/compliance uncertainty, execution risk in scaling domestic manufacturing, and residual contract issues that could still impair credibility. Net, the post reads as a defense of the long case against a short narrative, with the author suggesting better short targets elsewhere in the solar complex.

BSD Analysis:
This is ultimately a “bankability and bankability-of-supply-chain” story: in solar hardware, the durable winners will be those who can secure financing-grade offtake while meeting shifting trade, content, and eligibility rules that determine project economics. If TE is genuinely progressing toward a vertically integrated domestic value chain, that can translate into pricing power versus import-dependent module assemblers during policy-driven dislocations, even if industry ASPs remain cyclical. The bear case is less about product differentiation and more about execution and credibility—ramp delays, customer churn, or any compliance reversal can quickly collapse confidence and re-open dilution risk. Competitive intensity remains brutal, so TE’s edge must come from policy-enabled demand pull-through plus reliable delivery, not from commodity modules alone. The most important diligence items are (1) contract terms and credit quality of counterparties, (2) evidence of repeatable manufacturing yields/cost trajectory, and (3) funding plan to complete the next capacity phase without punitive equity issuance. If these clear, TE can re-rate on forward earnings power; if they don’t, the equity behaves like an option on policy and project timelines.

Actual Post Content:
Culpepper is short $TE https://culperresearch.com/wp-content/uploads/2026/01/Culper_TE_1-21-2026.pdf Their arguments are: 1. CEO is an awful human 2. It’s a SPAC 3. They are not FEOC compliant 4. The already disclosed problems with the RWE contract are in fact way worse Undercutting their short thesis is: 1. The recent contract with TreatyOak, who has offtakes with $META $GOOG and is owned by Macquarie. Basically Culpepper saying the legacy RWE contract issues > recent heavily due diligenced contract with TreatyOak 2. The company has raised significant capital 3. The company has outlined in granular terms both in investor meetings and public announcements why they are FEOC compliant 4. The “Sherpa” that has backed most of the recent financings and was over the wall on the Trina deal is Encompass (great firm) We would especially call out the decision to lead with the legacy personal dispute involving the CEO, as opposed to actual issues with the company. Liquid stock and has rallied a lot. People take shots. We think $CSIQ is the far better target if you are going to question FEOC and misleading guidance given they are 70% Chinese sourced. We deeply respect Culpepper as a firm and applaud both their work here as well as the vital role they play ensuring markets are fair and transparent. Great guys and well deserved congrats on a well timed attack - which we suspect started yesterday at $9 per share. $TE Tons of developments since our note last week. We update on the name. The Treaty Oak Deal this morning and $GOOG deal with Intercept underscore why $TE might be special. Solar will be a key source of power for AI. Implications also for $FSLR $CSIQ We also point investors to the excellent analyst team at Roth Capital of Philip Shen and Matt Ingraham who are the axe on the name and hosted a call with management last week. If you have a relationship, you should reach out. https://open.substack.com/pub/lakecornelia/p/t1-energy-te-even-better-than-we-thought.

URL: https://x.com/CorneliaLake/status/2014052786615234899

Pitch Summary:
Vodafone's current market valuation does not reflect the potential upside from its partnership with AST Spacemobile. The Sat-co joint venture with ASTS is poised to revolutionize connectivity in Europe by providing direct-to-device broadband and voice services without the need for additional hardware. This innovation could significantly reduce Vodafone's capital expenditure and improve its free cash flow. Despite Vodafone's current low valuation, the market has not yet priced in the potential earnings growth and structural savings from Sat-co. As Sat-co's services gain traction, Vodafone's earnings and valuation multiples could see substantial improvement.

BSD Analysis:
The market's oversight of Vodafone's Sat-co venture presents a unique investment opportunity. As the exclusive provider of ASTS's technology in Europe, Vodafone stands to benefit from the growing demand for seamless connectivity. The European mobile market's size and the strategic advantage of retaining EU sovereignty through the JV structure enhance Vodafone's competitive position. With defense and emergency services as key use cases, Sat-co's potential extends beyond commercial applications. As Vodafone's capital intensity decreases and earnings quality improves, the stock is well-positioned for a re-rating, similar to the tobacco industry's transformation with new product lines.

Pitch Summary:
Ashtead Technology Holdings plc is positioned as a leader in the niche subsea equipment rental market, benefiting from a strategic focus on offshore energy services. The company has demonstrated robust growth through a combination of organic expansion and strategic acquisitions, increasing its market share and enhancing its service offerings. With a strong emphasis on the energy transition, Ashtead Technology is poised to capitalize on the growing demand for offshore wind and decommissioning services. The company's disciplined approach to M&A and integration has resulted in significant operational synergies and a resilient business model. Despite the cyclical nature of the offshore energy sector, Ashtead Technology's diversified revenue streams and focus on high-margin services provide a buffer against market volatility. The current stock price reflects an undervaluation, with a potential upside of 54% based on conservative growth assumptions.

BSD Analysis:
Ashtead Technology's strategic acquisitions have expanded its capabilities and geographic reach, positioning it as a key player in the fragmented subsea equipment rental market. The company's focus on high-value, niche services reduces exposure to price competition and enhances customer loyalty. Its robust financial performance, characterized by strong revenue and EBITDA growth, underscores the effectiveness of its business strategy. The company's ability to maintain high fleet utilization and leverage its global network of service hubs provides a competitive edge. While regulatory risks and market cyclicality pose challenges, Ashtead Technology's proactive management and strategic focus on the energy transition mitigate these risks. The company's valuation appears attractive, with significant upside potential as the market recognizes its growth prospects and operational strengths.

Pitch Summary:
Glass House Brands is positioned to benefit from potential export opportunities for cannabis as a Schedule III substance. The company's focus on producing low-cost, high-quality cannabis products aligns well with the potential for international expansion. As the regulatory landscape evolves, Glass House could capitalize on new markets and enhance its growth prospects.

BSD Analysis:
The potential for exporting cannabis as a Schedule III substance presents a significant growth opportunity for Glass House Brands. The company's emphasis on producing high-quality, cost-effective products positions it well to compete in international markets. Navigating the regulatory requirements for exportation will be crucial, but Glass House's strategic focus on quality and cost efficiency could give it a competitive edge. As the market for cannabis expands globally, Glass House's ability to adapt and execute its growth strategy will be key to its success.

Pitch Summary:
Grown Rogue International is well-positioned to capitalize on the growth opportunities in Minnesota's emerging cannabis market. The state's limited flower production capacity presents a significant opportunity for Grown Rogue, which is prepared to meet the demand. Additionally, the potential for exporting cannabis as a Schedule III substance could open new markets for the company, enhancing its growth prospects.

BSD Analysis:
Minnesota's cannabis market offers substantial growth potential due to its limited cultivation capacity and increasing demand. Grown Rogue International is strategically positioned to benefit from this dynamic, with the potential to become a leading supplier in the state. Furthermore, the possibility of exporting cannabis as a Schedule III substance could provide additional growth avenues. The company's ability to navigate regulatory challenges and execute its growth strategy will be critical to its success in both domestic and international markets.

Pitch Summary:
Vireo Health International is strategically positioned to benefit from the growth potential in Minnesota's cannabis market. The state's limited flower production capacity presents a significant opportunity for Vireo, which is well-prepared to meet the demand. As Minnesota's market develops, Vireo's ability to supply the necessary cultivation capacity could lead to substantial growth and market share gains.

BSD Analysis:
The Minnesota cannabis market offers a unique opportunity due to its limited cultivation capacity and growing demand. Vireo Health International is well-positioned to capitalize on this dynamic, with the potential to become a leading supplier in the state. The company's strategic focus on expanding its cultivation capabilities and navigating regulatory requirements will be crucial to its success. As the market matures, Vireo's ability to adapt and execute its growth strategy will determine its long-term success in this promising market.

Pitch Summary:
Green Thumb Industries is well-positioned to capitalize on the growth opportunities in Minnesota's emerging adult-use cannabis market. The state is expected to require significant additional cultivation capacity, which presents a substantial opportunity for companies like Green Thumb that are ready to supply this demand. The company's strategic positioning in a market with limited flower production capacity could lead to significant growth as Minnesota's market develops.

BSD Analysis:
Minnesota's cannabis market is one of the few new adult-use markets with substantial growth potential. The state's limited cultivation capacity means that companies capable of meeting this demand stand to benefit significantly. Green Thumb Industries, with its established operations and strategic positioning, is poised to capture market share as Minnesota's cannabis industry expands. The company's ability to navigate regulatory challenges and execute on its growth strategy will be critical to its success in this promising market.

Pitch Summary:
Planet 13 is currently facing significant structural challenges that are not addressed by potential tax relief from cannabis rescheduling. The company is experiencing steep revenue declines and weak gross margins, which are not likely to be resolved by changes in tax policy alone. The cannabis market is undergoing price compression, and companies with weak business models are at risk. Planet 13's current financial health suggests that it may struggle to compete effectively in a rapidly evolving market.

BSD Analysis:
The potential rescheduling of cannabis to Schedule III could provide some tax relief, but this is unlikely to be a panacea for Planet 13's deeper issues. The company's structural problems, such as high expense structures and declining revenues, indicate that it may not benefit significantly from changes in tax policy. Furthermore, the competitive landscape is intensifying, with price compression likely to continue as the market expands. Planet 13 needs to address its core business challenges to improve its financial performance and remain competitive.

Pitch Summary:
OCI Global is currently undervalued due to a proposed merger with Orascom Construction, which has been criticized for disadvantaging minority shareholders. The merger implies a valuation of €3.73 per OCI share, but after tax, it is worth €3.17, while the stock trades at €3.00. Activist investor Norbury Capital estimates OCI's fair liquidation value at €7.10 per share, suggesting significant upside potential. The merger structure benefits the controlling shareholder, Nassef Sawiris, while minority shareholders face tax leakage and illiquidity issues. Norbury Capital is actively challenging the merger, and if successful, OCI's stock could rebound significantly.

BSD Analysis:
The merger between OCI Global and Orascom Construction is structured as a demerger followed by a share swap, which systematically disadvantages minority shareholders. The controlling shareholder, Nassef Sawiris, stands to benefit from the deal, while minority shareholders face a 15% Dutch Dividend Withholding Tax and potential illiquidity issues due to Orascom's listing on less accessible exchanges. Norbury Capital's involvement and their legal challenge under Dutch law could lead to a significant valuation uplift if successful. The potential for a cash buyout or a scrapped deal presents additional upside, making this a high-risk, high-reward investment opportunity.

Pitch Summary:
Majestic Gold operates the Songjiagou gold mine in China, benefiting from low valuation and high dividend yield. The company's profitability and potential revaluation if the 'China discount' is reduced highlight its investment appeal. However, geopolitical risks and difficulties in repatriating profits from China pose challenges.

BSD Analysis:
Majestic Gold's focus on low-cost gold production positions it as a leader in the mining sector. The company's high dividend yield and potential for revaluation provide a compelling investment opportunity. As geopolitical tensions ease, the market may reassess the 'China discount,' enhancing Majestic Gold's valuation. Investors should consider the potential impact of geopolitical risks and challenges in repatriating profits from China on the company's financial performance.

Pitch Summary:
Cyviz offers high-end technology solutions for control and conference rooms, with a strong client base including Microsoft and the US Department of Defense. The company's standardized platform and strong order intake highlight its growth potential. However, revenue fluctuations and low stock liquidity pose challenges.

BSD Analysis:
Cyviz's focus on providing standardized, IT-based solutions for control and conference rooms positions it as a leader in the technology sector. The company's strong client relationships and growing order backlog support its growth trajectory. As demand for remote management solutions increases, Cyviz is well-positioned to capture market share. Investors should consider the potential impact of revenue fluctuations due to project timing and the low liquidity of the stock on the company's financial performance.

Pitch Summary:
Neo Performance Materials processes rare earths, owning the only commercial separation plant in Europe. The company's strategic position in the European automotive industry enhances its growth potential. However, price volatility for rare earths and China's market dominance pose challenges.

BSD Analysis:
Neo Performance Materials' focus on processing rare earths positions it as a key supplier to the European automotive industry. The company's commercial separation plant in Estonia provides a strategic advantage, ensuring a stable supply of critical materials. As demand for electric motors and rare earths continues to rise, Neo is well-positioned to capture market share. Investors should consider the impact of price volatility and China's influence on the rare earths market on the company's growth prospects.

Pitch Summary:
5N Plus is a world leader in ultra-pure materials for satellite solar panels, benefiting from the space sector's growth. The company's strong revenue and EBITDA performance highlight its potential. However, production complexity and dependence on a few major customers pose challenges.

BSD Analysis:
5N Plus's focus on specialty semiconductors and high-performance materials positions it as a leader in the space and medical imaging sectors. The company's expertise in producing ultra-pure materials provides a competitive edge, ensuring high demand from satellite manufacturers. As the space sector continues to expand, 5N Plus is well-positioned to capture market share. Investors should monitor the complexity of production processes and the company's reliance on a limited customer base for revenue generation.